API
RDY icon

Advisor Partners II’s Dr. Reddy's Laboratories RDY Stock Holding History

Advisor Partners II’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$878K Buy
65,630
+29,055
+79% +$393K 0.04% 524
2023
Q2 		$462K Buy
36,575
+6,370
+21% +$74.4K 0.02% 635
2023
Q1 		$344K Buy
+30,205
New +$326K 0.02% 673

Other funds holding RDY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

Advisor Partners II's RDY Position: Q3 2023 in Review

Advisor Partners II increased its Dr. Reddy's Laboratories (RDY) stake by 79% in Q3 2023, buying an estimated $393K and bringing the position to 65,630 shares worth $878K. The position accounts for 0.04% of the portfolio, ranked #524.

Advisor Partners II first reported a position in RDY in Q1 2023 and has held it in 3 quarters since. 212 funds tracked by Wall St. Rank hold RDY as of Q3 2023.

  • Advisor Partners II held 65,630 shares of Dr. Reddy's Laboratories worth $878K as of Q3 2023.
  • Advisor Partners II bought 29,055 Dr. Reddy's Laboratories shares in Q3 2023, an estimated $393K.
  • Dr. Reddy's Laboratories made up 0.04% of Advisor Partners II's portfolio in Q3 2023, its #524 holding.
  • Advisor Partners II first reported a position in Dr. Reddy's Laboratories in Q1 2023 and has held it in 3 quarters since.
  • 212 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2023.

Based on Advisor Partners II's 13F filing for Q3 2023, filed 26 Oct 2023.